767 related articles for article (PubMed ID: 16337092)
81. Glia as a turning point in the therapeutic strategy of Parkinson's disease.
L' Episcopo F; Tirolo C; Testa N; Caniglia S; Morale MC; Marchetti B
CNS Neurol Disord Drug Targets; 2010 Jul; 9(3):349-72. PubMed ID: 20438439
[TBL] [Abstract][Full Text] [Related]
82. Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2.
Knott C; Stern G; Wilkin GP
Mol Cell Neurosci; 2000 Dec; 16(6):724-39. PubMed ID: 11124893
[TBL] [Abstract][Full Text] [Related]
83. Interactions between MPTP-induced and age-related neuronal death in a murine model of Parkinson's disease.
Tatton WG; Greenwood CE; Seniuk NA; Salo PT
Can J Neurol Sci; 1992 Feb; 19(1 Suppl):124-33. PubMed ID: 1571857
[TBL] [Abstract][Full Text] [Related]
84. [Neuronal death caused by apoptosis in Parkinson disease].
Ruberg M; France-Lanord V; Brugg B; Lambeng N; Michel PP; Anglade P; Hunot S; Damier P; Faucheux B; Hirsch E; Agid Y
Rev Neurol (Paris); 1997 Sep; 153(8-9):499-508. PubMed ID: 9683999
[TBL] [Abstract][Full Text] [Related]
85. Selective cell death in neurodegeneration: why are some neurons spared in vulnerable regions?
Double KL; Reyes S; Werry EL; Halliday GM
Prog Neurobiol; 2010 Nov; 92(3):316-29. PubMed ID: 20541584
[TBL] [Abstract][Full Text] [Related]
86. Neuroinflammatory processes in Parkinson's disease.
Hunot S; Hirsch EC
Ann Neurol; 2003; 53 Suppl 3():S49-58; discussion S58-60. PubMed ID: 12666098
[TBL] [Abstract][Full Text] [Related]
87. Do alterations in glutathione and iron levels contribute to pathology associated with Parkinson's disease?
Andersen JK
Novartis Found Symp; 2001; 235():11-20; discussion 20-5. PubMed ID: 11280021
[TBL] [Abstract][Full Text] [Related]
88. Parkinson's disease in the nuclear age of neuroinflammation.
Nolan YM; Sullivan AM; Toulouse A
Trends Mol Med; 2013 Mar; 19(3):187-96. PubMed ID: 23318001
[TBL] [Abstract][Full Text] [Related]
89. Neuroprotection in Parkinson's disease: love story or mission impossible?
Linazasoro GJ
Expert Rev Neurother; 2002 May; 2(3):403-16. PubMed ID: 19810872
[TBL] [Abstract][Full Text] [Related]
90. The influence of microglia on the pathogenesis of Parkinson's disease.
Long-Smith CM; Sullivan AM; Nolan YM
Prog Neurobiol; 2009 Nov; 89(3):277-87. PubMed ID: 19686799
[TBL] [Abstract][Full Text] [Related]
91. Oxidative stress indices in Parkinson's disease : biochemical determination.
Youdim MB; Drigues N; Mandel S
Methods Mol Med; 2001; 62():137-53. PubMed ID: 21318773
[TBL] [Abstract][Full Text] [Related]
92. The contributions of antioxidant activity of lipoic acid in reducing neurogenerative progression of Parkinson's disease: a review.
De Araújo DP; Lobato Rde F; Cavalcanti JR; Sampaio LR; Araújo PV; Silva MC; Neves KR; Fonteles MM; Sousa FC; Vasconcelos SM
Int J Neurosci; 2011 Feb; 121(2):51-7. PubMed ID: 21126109
[TBL] [Abstract][Full Text] [Related]
93. Metformin Prevents Dopaminergic Neuron Death in MPTP/P-Induced Mouse Model of Parkinson's Disease via Autophagy and Mitochondrial ROS Clearance.
Lu M; Su C; Qiao C; Bian Y; Ding J; Hu G
Int J Neuropsychopharmacol; 2016 Sep; 19(9):. PubMed ID: 27207919
[TBL] [Abstract][Full Text] [Related]
94. Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration?
Hirsch EC; Hunot S; Damier P; Faucheux B
Ann Neurol; 1998 Sep; 44(3 Suppl 1):S115-20. PubMed ID: 9749582
[TBL] [Abstract][Full Text] [Related]
95. NG2 glia regulate brain innate immunity via TGF-β2/TGFBR2 axis.
Zhang SZ; Wang QQ; Yang QQ; Gu HY; Yin YQ; Li YD; Hou JC; Chen R; Sun QQ; Sun YF; Hu G; Zhou JW
BMC Med; 2019 Nov; 17(1):204. PubMed ID: 31727112
[TBL] [Abstract][Full Text] [Related]
96. Novel anti-inflammatory therapy for Parkinson's disease.
Gao HM; Liu B; Zhang W; Hong JS
Trends Pharmacol Sci; 2003 Aug; 24(8):395-401. PubMed ID: 12915048
[TBL] [Abstract][Full Text] [Related]
97. [Mechanism of cell death in neurodegenerative disorders: apropos of Parkinson disease].
Agid Y
C R Seances Soc Biol Fil; 1993; 187(1):37-46. PubMed ID: 8242421
[TBL] [Abstract][Full Text] [Related]
98. Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention.
Tansey MG; Goldberg MS
Neurobiol Dis; 2010 Mar; 37(3):510-8. PubMed ID: 19913097
[TBL] [Abstract][Full Text] [Related]
99. Microglia and neuroprotection: implications for Alzheimer's disease.
Streit WJ
Brain Res Brain Res Rev; 2005 Apr; 48(2):234-9. PubMed ID: 15850662
[TBL] [Abstract][Full Text] [Related]
100. The role of the estrogen in neuroprotection: implications for neurodegenerative diseases.
Cho JJ; Iannucci FA; Fraile M; Franco J; Alesius TN; Stefano GB
Neuro Endocrinol Lett; 2003; 24(3-4):141-7. PubMed ID: 14523347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
